Action at a distance: Epigenetic silencing of large chromosomal regions in carcinogenesis

Human Molecular Genetics

Volumn 16, Issue R1, 2007, Pages

  Clark, Susan J ^a  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DEATH RECEPTOR 4; DEATH RECEPTOR 5; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; DOUBLE STRANDED DNA; GENOMIC DNA; HISTONE H2A; HISTONE H2B; HISTONE H3; HISTONE H4; HLA ANTIGEN CLASS 1; MICRORNA; PROTEIN MLH1; SOMATOMEDIN B RECEPTOR; TRANSCRIPTION FACTOR PAX5; UNTRANSLATED RNA;

BLADDER CANCER; BREAST CANCER; CANCER DIAGNOSIS; CANCER GENETICS; CARCINOGENESIS; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMOSOME SIZE; COLORECTAL CANCER; CPG ISLAND; DIAGNOSTIC VALUE; DNA METHYLATION; ENZYME ACTIVITY; EPIGENETICS; ESOPHAGUS CANCER; GENE DELETION; GENE EXPRESSION REGULATION; GENE SILENCING; GENETIC TRANSCRIPTION; HETEROCHROMATIN; HUMAN; HUMAN GENOME PROJECT; LUNG CANCER; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN MODIFICATION; REVIEW; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

CHROMATIN; CHROMOSOMES, HUMAN; CPG ISLANDS; DNA METHYLATION; EPIGENESIS, GENETIC; GENE SILENCING; HUMANS; NEOPLASMS; RNA, NEOPLASM; RNA, UNTRANSLATED;

EID: 34547765951     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddm051     Document Type: Review

References (108)

1. Jones, P.A. (2002) DNA methylation and cancer. Oncogene, 21, 5358-5360.
2. Jones, P.A. and Baylin, S.B. (2002) The fundamental role of epigenetic events in cancer. Nat. Rev. Genet., 3, 415-428.
3. Jones, P.A. (2003) Epigenetics in carcinogenesis and cancer prevention. Ann. N.Y. Acad. Sci., 983, 213-219.
4. Lund, A.H. and van Lohuizen, M. (2004) Epigenetics and cancer. Genes Dev., 18, 2315-2335.
5. Feinberg, A.P. and Tycko, B. (2004) The history of cancer epigenetics. Nat. Rev. Cancer, 4, 143-153.
6. Feinberg, A.P. (2004) The epigenetics of cancer etiology. Semin. Cancer Biol., 14, 427-432.
7. Laird, P.W. (2005) Cancer epigenetics. Hum. Mol. Genet., 14, R65-R76.
8. Baylin, S.B. and Ohm, J.E. (2006) Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction? Nat. Rev. Cancer 6, 107-116.
9. Feinberg, A.P., Ohlsson, R. and Henikoff, S. (2006) The epigenetic progenitor origin of human cancer. Nat Rev. Genet., 7, 21-33.
10. Ting, A.H., McGarvey, K.M. and Baylin, S.B. (2006) The cancer epigenome-components and functional correlates. Genes Dev., 20 3215-3231.
11. Ehrlich, M., Gama-Sosa, M.A., Huang, L.H., Midgett, R.M., Kuo, K.C., McCune, R.A. and Gehrke, C. (1982) Amount and distribution of 5-methylcytosine in human DNA from different types of tissues of cells. Nucleic Acids Res., 10, 2709-2721.
12. Gardiner-Garden, M. and Frommer, M. (1987) CpG islands in vertebrate genomes. J. Mol. Biol., 196, 261-282.
13. Takai, D. and Jones, P.A. (2003) The CpG island searcher: A new WWW resource. In Silico Biol., 3, 235-240.
14. Lander, E.S., Linton, L.M., Birren, B., Nusbaum, C., Zody, M.C., Baldwin, J., Devon, K., Dewar, K., Doyle, M., FitzHugh, W. et al. (2001) Initial sequencing and analysis of the human genome. Nature 409, 860-921.
15. Venter, J.C., Adams, M.D., Myers, E.W., Li, P.W., Mural, R.J., Sutton, G.G., Smith, H.O., Yandell, M., Evans, C.A., Holt, R.A. et al., (2001) The sequence of the human genome. Science, 291, 1304-1351.
16. Antequera, F. and Bird, A. (1993) Number of CpG islands and genes in human and mouse. Proc. Natl. Acad. Sci. USA, 90, 11995-11999.
17. Bird, A. (2002) DNA methylation patterns and epigenetic memory. Genes Dev., 16, 6-21.
18. Holliday, R. and Pugh, J.E. (1975) DNA modification mechanisms and gene activity during development. Science, 187, 226-232.
19. Riggs, A.D. (1975) X inactivation, differntiation and DNA methylation. Cytogenet. Cell Genet., 14, 9-25.
20. Monk, M. (1990) Changes in DNA methylation during mouse embryonic development in relation to X-chromosome activity and imprinting. Philos. Trans. R. Soc. Lond. (Biol.), 326, 299-312.
21. Howlett, S.K. and Reik, W. (1991) Methylation levels of maternal and paternal genomes during preimplantation development. Development, 113, 119-127.
22. Mayer, W., Niveleau, A., Walter, J., Fundele, R. and Haaf, T. (2000) Demethylation of the zygotic paternal genome. Nature, 403, 501-502.
23. Reik, W., Dean, W. and Walter, J. (2001) Epigenetic reprogramming in mammalian development. Science, 293, 1089-1093.
24. Santos, F., Hendrich, B., Reik, W. and Dean, W. (2002) Dynamic reprogramming of DNA methylation in the early mouse embryo. Dev. Biol., 241, 172-182.
25. Reik, W., Santos, F., Mitsuya, K., Morgan, H. and Dean, W. (2003) Epigenetic asymmetry in the mammalian zygote and early embryo: relationship to lineage commitment? Philos. Trans. R. Soc. Lond. B. Biol. Sci., 358, 1403-1409.
26. Morgan, H.D., Santos, F., Green, K., Dean, W. and Reik, W. (2005) Epigenetic reprogramming in mammals. Hum. Mol. Genet., 14 (Spec No. 1), R47-R58.
27. Eilertsen, K.J., Power, R.A., Harkins, L.L. and Misica, P. (2006) Targeting cellular memory to reprogram the epigenome, restore potential, and improve somatic cell nuclear transfer. Anim. Reprod. Sci., 98, 129-146.
28. Clark, S.J., Harrison, J., Paul, C.L. and Frommer, M. (1994) High sensitivity mapping of methylated cytosines. Nucl. Acids Res., 22, 2990-2997.
29. Stirzaker, C., Millar, D.S., Paul, C.L., Warnecke, P.M., Harrison, J., Vincent, P.C., Frommer, M. and Clark, S.J. (1997) Extensive DNA methylation spanning the Rb promoter in retinoblastoma tumors. Cancer Res., 57, 2229-2237.
30. Stoger, R., Kajimura, T.M., Brown, W.T. and Laird, C.D. (1997) Epigenetic variation illustrated by DNA methylation patterns of the fragile-X gene FMR1. Hum. Mol. Genet., 6, 1791-1801.
31. Warnecke, P.M. and Clark, S.C. (1999) DNA methylation profile of the mouse skeletal a-actin promoter during development and differentiation. Mol. Cell. Biol., 19, 164-172.
32. Riggs, A.D., Xiong, Z., Wang, L. and LeBon, J.M. (1998) Methylation dynamics, epigenetic fidelity and X chromosome structure. Novartis Found. Symp., 214, 214-232.
33. Rhee, I., Jair, K.W., Yen, R.W., Lengauer, C., Herman, J.G., Kinzler, K.W., Vogelstein, B., Baylin, S.B. and Schuebel, K.E. (2000) CpG methylation is maintained in human cancer cells lacking DNMT1. Nature 404, 1003-1007.
34. Jaenisch, R. (1997) DNA methylation and imprinting: Why bother? Trends Genet., 13, 323-329.
35. Okano, M., Bell, D.W., Haber, D.A. and Li, E. (1999) DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell, 99, 247-257.
36. Okano, M., Xie, S. and Li, E. (1998) Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases. Nature Genet., 19, 219-220.
37. Bestor, T., Laudano, A., Mattaliano, R. and Ingram, V. (1988) Cloning and sequencing of a cDNA encoding DNA methyltransferase of mouse cells. The carboxyl-terminal domain of the mammalian enzymes is related to bacterial restriction methyltransferases. J. Mol. Biol., 203 971-983.
38. Dennis, K., Fan, T., Geiman, T., Yan, Q. and Muegge, K. (2001) Lsh, a member of the SNF2 family, is required for genome-wide methylation. Genes Dev., 15, 2940-2944.
39. Zhu, H., Geiman, T.M., Xi, S., Jiang, Q., Schmidtmann, A., Chen, T., Li, E. and Muegge, K. (2006) Lsh is involved in de novo methylation of DNA. Embo J., 25, 335-345.
40. Turker, M.S. (2002) Gene silencing in mammalian cells and the spread of DNA methylation. Oncogene, 21, 5388-5393.
41. Feltus, F.A., Lee, E.K., Costello, J.F., Plass, C. and Vertino, P.M. (2003) Predicting aberrant CpG island methylation. Proc. Natl. Acad. Sci. USA, 100, 12253-12258.
42. Bock, C., Paulsen, M., Tierling, S., Mikeska, T., Lengauer, T. and Walter, J. (2006) CpG island methylation in human lymphocytes is highly correlated with DNA sequence, repeats, and predicted DNA structure. PLoS Genet., 2, e26.
43. Feltus, F.A., Lee, E.K., Costello, J.F., Plass, C. and Vertino, P.M. (2006) DNA motifs associated with aberrant CpG island methylation. Genomics, 87, 572-579.
44. Tagoh, H., Schebesta, A., Lefevre, P., Wilson, N., Hume, D., Busslinger, M. and Bonifer, C. (2004) Epigenetic silencing of the c-fms locus during B-lymphopoiesis occurs in discrete steps and is reversible. Embo J. 23, 4275-4285.
45. Shemer, R., Eisenberg, S., Breslow, J.L. and Razin, A. (1991) Methylation patterns of the human apoA-I/C-III/A-IV gene cluster in adult and embryonic tissues suggest dynamic changes in methylation during development. J. Biol. Chem., 266, 23676-23681.
46. Shemer, R., Kafri, T., O'Connell, A., Eisenberg, S., Breslow, J.L. and Razin, A. (1991) Methylation changes in the apolipoprotein AI gene during embryonic development of the mouse. Proc. Natl. Acad. Sci. USA 88, 11300-11304.
47. Wassenegger, M. (2000) RNA-directed DNA methylation. Plant Mol. Biol. 43, 203-220.
48. Matzke, M.A., Matzke, A.J., Pruss, G.J. and Vance, V.B. (2001) RNA-based silencing strategies in plants. Curr. Opin. Genet. Dev., 11, 221-227.
49. Qi, Y., He, X., Wang, X.J., Kohany, O., Jurka, J. and Hannon, G.J. (2006) Distinct catalytic and non-catalytic roles of ARGONAUTE4 in RNA-directed DNA methylation. Nature, 443, 1008-1012.
50. Mette, M.F., Aufsatz, W., van der Winden, J., Matzke, M.A. and Matzke, A.J. (2000) Transcriptional silencing and promoter methylation triggered by double-stranded RNA. Embo J., 19, 5194-5201.
51. Ting, A.H., Schuebel, K.E., Herman, J.G. and Baylin, S.B. (2005) Short double-stranded RNA induces transcriptional gene silencing in human cancer cells in the absence of DNA methylation. Nat. Genet., 37 906-910.
52. Li, E., Bestor, T.H. and Jaenisch, R. (1992) Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell, 69, 915-926.
53. Jones, P.A. and Laird, P.W. (1999) Cancer epigenetics comes of age. Nat. Genet., 21, 163-167.
54. Jenuwein, T. and Allis, C.D. (2001) Translating the histone code. Science, 293, 1074-1080.
55. Turner, B.M. (2002) Cellular memory and the histone code. Cell, 111, 285-291.
56. Plath, K., Fang, J., Mlynarczyk-Evans, S.K., Cao, R., Worringer, K.A., Wang, H., de la Cruz, C.C., Otte, A.P., Panning, B. and Zhang, Y. (2003) Role of histone H3 lysine 27 methylation in X inactivation. Science 300, 131-135.
57. Jacobs, S.A., Taverna, S.D., Zhang, Y., Briggs, S.D., Li, J., Eissenberg, J.C., Allis, C.D. and Khorasanizadeh, S. (2001) Specificity of the HP1 chromo domain for the methylated N-terminus of histone H3. Embo J., 20, 5232-5241.
58. Lund, A.H. and van Lohuizen, M. (2004) Polycomb complexes and silencing mechanisms. Curr. Opin. Cell Biol., 16, 239-246.
59. Carrel, L. (2006) Molecular biology. 'X'-rated chromosomal rendezvous. Science, 311, 1107-1109.
60. Vu, T.H., Jirtle, R.L. and Hoffman, A.R. (2006) Cross-species clues of an epigenetic imprinting regulatory code for the IGF2R gene. Cytogenet. Genome Res., 113, 202-208.
61. Tufarelli, C., Stanley, J.A., Garrick, D., Sharpe, J.A., Ayyub, H., Wood, W.G. and Higgs, D.R. (2003) Transcription of antisense RNA leading to gene silencing and methylation as a novel cause of human genetic disease. Nat. Genet., 34, 157-165.
62. Stolc, V., Samanta, M.P., Tongprasit, W., Sethi, H., Liang, S., Nelson, D.C., Hegeman, A., Nelson, C., Rancour, D., Bednarek, S. et al., (2005) Identification of transcribed sequences in Arabidopsis thaliana by using high-resolution genome tiling arrays. Proc. Natl. Acad. Sci. USA, 102, 4453-4458.
63. Esquela-Kerscher, A. and Slack, F.J. (2006) Oncomirs-microRNAs with a role in cancer. Nat. Rev. Cancer, 6, 259-269.
64. Wilson, A.S., Power, B.E. and Molloy, P.L. (2007) DNA hypomethylation and human diseases. Biochim. Biophys. Acta, 1775, 138-162.
65. Melki, J.M., Vincent, P.C. and Clark, S.J. (1999) Concurrent DNA hypermethylation of multiple genes in Acute Myeloid Leukaemia. Cancer Res., 59, 3730-3740.
66. Suzuki, H., Gabrielson, E., Chen, W., Anbazhagan, R., van Engeland, M., Weijenberg, M.P., Herman, J.G. and Baylin, S.B. (2002) A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat. Genet., 31, 141-149.
67. Costello, J.F., Fruhwald, M.C., Smiraglia, D.J., Rush, L.J., Robertson, G.P., Gao, X., Wright, F.A., Feramisco, J.D., Peltomaki, P., Lang, J.C. et al., (2000) Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat. Genet., 24, 132-138.
68. Costello, J.F. and Plass, C. (2001) Methylation matters. J. Med. Genet., 38, 285-303.
69. Frigola, J., Song, J., Stirzaker, C., Hinshelwood, R.A., Peinado, M.A. and Clark, S.J. (2006) Epigenetic remodeling in colorectal cancer results in coordinate gene suppression across an entire chromosome band. Nat. Genet., 38, 540-549.
70. Nie, Y., Yang, G., Song, Y., Zhao, X., So, C., Liao, J., Wang, L.D. and Yang, C.S. (2001) DNA hypermethylation is a mechanism for loss of expression of the HLA class I genes in human esophageal squamous cell carcinomas. Carcinogenesis, 22, 1615-1623.
71. van Noesel, M.M., van Bezouw, S., Voute, P.A., Herman, J.G., Pieters, R. and Versteeg, R. (2003) Clustering of hypermethylated genes in neuroblastoma. Genes Chromosomes Cancer, 38, 226-233.
72. Palmisano, W.A., Crume, K.P., Grimes, M.J., Winters, S.A., Toyota, M., Esteller, M., Joste, N., Baylin, S.B. and Belinsky, S.A. (2003) Aberrant promoter methylation of the transcription factor genes PAX5 alpha and beta in human cancers. Cancer Res., 63, 4620-4625.
73. Novak, P., Jensen, T., Oshiro, M.M., Wozniak, R.J., Nouzova, M., Watts, G.S., Klimecki, W.T., Kim, C. and Futscher, B.W. (2006) Epigenetic inactivation of the HOXA gene cluster in breast cancer. Cancer Res. 66, 10664-10670.
74. Smith, L.T., Lin, M., Brena, R.M., Lang, J.C., Schuller, D.E., Otterson, G.A., Morrison, C.D., Smiraglia, D.J. and Plass, C. (2006) Epigenetic regulation of the tumor suppressor gene TCF21 on 6q23-q24 in lung and head and neck cancer. Proc. Natl. Acad. Sci. USA, 103, 982-987.
75. Stransky, N., Vallot, C., Reyal, F., Bernard-Pierrot, I., de Medina, S.G., Segraves, R., de Rycke, Y., Elvin, P., Cassidy, A., Spraggon, C. et al., (2006) Regional copy number-independent deregulation of transcription in cancer. Nat. Genet., 38, 1386-1396.
76. Brockdorff, N. (2002) X-chromosome inactivation: Closing in on proteins that bind Xist RNA. Trends Genet., 18, 352-358.
77. Latham, K.E. (2005) X chromosome imprinting and inactivation in preimplantation mammalian embryos. Trends Genet., 21, 120-127.
78. Plath, K., Mlynarczyk-Evans, S., Nusinow, D.A. and Panning, B. (2002) Xist RNA and the mechanism of X chromosome inactivation. Ann. Rev. Genet., 36, 233-278.
79. Morris, K.V., Chan, S.W., Jacobsen, S.E. and Looney, D.J. (2004) Small interfering RNA-induced transcriptional gene silencing in human cells. Science, 305, 1289-1292.
80. Jones, P.A. and Buckley, J.D. (1990) The role of DNA methylation in cancer. Adv. Cancer Res., 54, 1-23.
81. Laird, P.W. and Jaenisch, R. (1994) DNA methylation and cancer. Hum. Mol. Genet., 3, 1487-1495.
82. Jones, P.A. and Gonzalgo, M.L. (1997) Altered DNA methylation and genome instability: A new pathway to cancer? Proc. Natl. Acad. Sci. USA, 94, 2103-2105.
83. Lin, H., Yamada, Y., Nguyen, S., Linhart, H., Jackson-Grusby, L., Meissner, A., Meletis, K., Lo, G. and Jaenisch, R. (2006) Suppression of intestinal neoplasia by deletion of Dnmt3b. Mol. Cell. Biol., 26, 2976-2983.
84. Clark, S.J. and Melki, J. (2002) DNA methylation and gene silencing in cancer: Which is the guilty party? Oncogene, 21, 5380-5387.
85. Baylin, S. and Bestor, T.H. (2002) Altered methylation patterns in cancer cell genomes: Cause or consequence? Cancer Cell, 1, 299-305.
86. Song, J., Stirzaker, C., Harrison, J., Melki, J. and Clark, S. (2002) Hypermethylation trigger of the glutathione-S-transferase gene (GSTP1) in prostate cancer cells. Oncogene, 21, 1048-1061.
87. Stirzaker, C., Song, J.Z., Davidson, B. and Clark, S.J. (2004) Transcriptional gene silencing promotes DNA hypermethylation through a sequential change in chromatin modifications in cancer cells. Cancer Res., 64, 3871-3877.
88. Mutskov, V. and Felsenfeld, G. (2004) Silencing of transgene transcription precedes methylation of promoter DNA and histone H3 lysine 9. Embo J., 23, 138-149.
89. Espada, J., Ballestar, E., Fraga, M.F., Villar-Garea, A., Juarranz, A., Stockert, J.C., Robertson, K.D., Fuks, F. and Esteller, M. (2004) Human DNA methyltransferase 1 is required for maintenance of the histone H3 modification pattern. J. Biol. Chem., 279, 37175-37184.
90. Bachman, K.E., Park, B.H., Rhee, I., Rajagopalan, H., Herman, J.G., Baylin, S.B., Kinzler, K.W. and Vogelstein, B. (2003) Histone modifications and silencing prior to DNA methylation of a tumor suppressor gene. Cancer Cell, 3, 89-95.
91. Lehnertz, B., Ueda, Y., Derijck, A.A., Braunschweig, U., Perez-Burgos, L., Kubicek, S., Chen, T., Li, E., Jenuwein, T. and Peters, A.H. (2003) Suv39 h-mediated histone H3 lysine 9 methylation directs DNA methylation to major satellite repeats at pericentric heterochromatin. Curr. Biol., 13, 1192-1200.
92. Bracken, A.P., Dietrich, N., Pasini, D., Hansen, K.H. and Helin, K. (2006) Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions. Genes Dev., 20, 1123-1136.
93. Sparmann, A. and van Lohuizen, M. (2006) Polycomb silencers control cell fate, development and cancer. Nat. Rev. Cancer, 6, 846-856.
94. Schlesinger, Y., Straussman, R., Keshet, I., Farkash, S., Hecht, M., Zimmerman, J., Eden, E., Yakhini, Z., Ben-Shushan, E., Reubinoff, B.E. et al., (2007) Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer. Nat. Genet, 39, 232-236.
95. Widschwendter, M., Fiegl, H., Egle, D., Mueller-Holzner, E., Spizzo, G., Marth, C., Weisenberger, D.J., Campan, M., Young, J., Jacobs, I. et al., (2007) Epigenetic stem cell signature in cancer. Nat. Genet. 39, 157-158.
96. Santos-Reboucas, C.B. and Pimentel, M.M. (2007) Implication of abnormal epigenetic patterns for human diseases. Eur. J. Hum. Genet., 15 10-17.
97. Ohm, J.E., McGarvey, K.M., Yu, X., Cheng, L., Schuebel, K.E., Cope, L., Mohammad, H.P., Chen, W., Daniel, V.C., Yu, W. et al., (2007) A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nat. Genet., 39, 237-242.
98. Bachmann, I.M., Halvorsen, O.J., Collett, K., Stefansson, I.M., Straume, O., Haukaas, S.A., Salvesen, H.B., Otte, A.P. and Akslen, L.A. (2006) EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast. J. Clin. Oncol., 24, 268-273.
99. Saramaki, O.R., Tammela, T.L., Martikainen, P.M., Vessella, R.L. and Visakorpi, T. (2006) The gene for polycomb group protein enhancer of zeste homolog 2 (EZH2) is amplified in late-stage prostate cancer. Genes Chromosomes Cancer, 45, 639-645.
100. Lorincz, M.C., Schubeler, D., Hutchinson, S.R., Dickerson, D.R. and Groudine, M. (2002) DNA methylation density influences the stability of an epigenetic imprint and Dnmt3a/b-independent de novo methylation. Mol. Cell. Biol., 22, 7572-7580.
101. Lorincz, M.C., Dickerson, D.R., Schmitt, M. and Groudine, M. (2004) Intragenic DNA methylation alters chromatin structure and elongation efficiency in mammalian cells. Nat. Struct. Mol. Biol., 11, 1068-1075.
102. Keshet, I., Schlesinger, Y., Farkash, S., Rand, E., Hecht, M., Segal, E., Pikarski, E., Young, R.A., Niveleau, A., Cedar, H. et al., (2006) Evidence for an instructive mechanism of de novo methylation in cancer cells. Nat. Genet., 38, 149-153.
103. Volpe, T.A., Kidner, C., Hall, I.M., Teng, G., Grewal, S.I. and Martienssen, R.A. (2002) Regulation of heterochromatic silencing and histone H3 lysine-9 methylation by RNAi. Science, 297, 1833-1837.
104. Volpe, T., Schramke, V., Hamilton, G.L., White, S.A., Teng, G., Martienssen, R.A. and Allshire, R.C. (2003) RNA interference is required for normal centromere function in fission yeast. Chromosome Res., 11, 137-146.
105. Cam, H. and Grewal, S.I. (2004) RNA interference and epigenetic control of heterochromatin assembly in fission yeast. Cold Spring Harb. Symp. Quant. Biol., 69, 419-427.
106. Hansen, K.R., Burns, G., Mata, J., Volpe, T.A., Martienssen, R.A., Bahler, J. and Thon, G. (2005) Global effects on gene expression in fission yeast by silencing and RNA interference machineries. Mol. Cell Biol., 25, 590-601.
107. Eckhardt, F., Lewin, J., Cortese, R., Rakyan, V.K., Attwood, J., Burger, M., Burton, J., Cox, T.V., Davies, R., Down, T.A. et al., (2006) DNA methylation profiling of human chromosomes 6, 20 and 22. Nat. Genet., 38, 1378-1385.
108. Brena, R.M., Huang, T.H. and Plass, C. (2006) Toward a human epigenome. Nat. Genet., 38, 1359-1360.